Camphor 12 % / eucalyptus oil 7 % / menthol 11 % / peppermint oil 6 % Topical Ointment
RxNorm 1997186

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1997186 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: camphor 12 % / eucalyptus oil 7 % / menthol 11 % / peppermint oil 6 % Topical Ointment.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCD
Camphor 0.12 mg/MG / Eucalyptus oil 0.07 mg/MG / menthol 0.11 mg/MG / peppermint oil 0.06 mg/MG Topical Ointment
Primary clinical definition
AUI:12332246
View
PSN
Camphor 12 % / eucalyptus oil 7 % / menthol 11 % / peppermint oil 6 % Topical Ointment
AUI:9718085
View
SY
Camphor 12 % / eucalyptus oil 7 % / menthol 11 % / peppermint oil 6 % Topical Ointment
AUI:9718086
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCD

Semantic Clinical Drug (SCD):
Camphor 0.12 mg/MG / Eucalyptus oil 0.07 mg/MG / menthol 0.11 mg/MG / peppermint oil 0.06 mg/MG Topical Ointment
(Atom ID: 12332246)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
camphor 0.12 MG/MG / Eucalyptus oil 0.07 MG/MG / menthol 0.11 MG/MG / peppermint oil 0.06 MG/MG Topical Ointment
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1997186
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12332246
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCD
Semantic Clinical Drug (Ingredient + Strength + Dose Form)
Source Code
1997186
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{1089846} 6750
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1806687} 1952
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1997181} 59087
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1997182} 33094
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{1089846} 6750
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1806687} 1952
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1997181} 59087
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1997182} 33094
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1089846} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1806687} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1997181} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1997182} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN OBSOLETED
11/28/2023
Date the RxNorm atom became obsolete
RXTERM FORM
Ointment
The RxTerm dose form name for this drug
PSN

Prescribable Name (PSN):
Camphor 12 % / eucalyptus oil 7 % / menthol 11 % / peppermint oil 6 % Topical Ointment
(Atom ID: 9718085)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
camphor 12 % / eucalyptus oil 7 % / menthol 11 % / peppermint oil 6 % Topical Ointment
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1997186
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
9718085
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
1997186
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SY

Synonym (SY):
Camphor 12 % / eucalyptus oil 7 % / menthol 11 % / peppermint oil 6 % Topical Ointment
(Atom ID: 9718086)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
camphor 12 % / eucalyptus oil 7 % / menthol 11 % / peppermint oil 6 % Topical Ointment
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1997186
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
9718086
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1997186
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Eucalyptus


What is it? Eucalyptus is a tree. Its leaves and oil have been consumed, chewed, and applied to the skin for many conditions.

Eucalyptus contains many different chemicals. These chemicals might have various effects in the body. Also, some research suggests that eucalyptus may have activity against bacteria and fungi.

People use eucalyptus for many conditions including asthma, bronchitis, flu (influenza), and many others, but there is no good scientific evidence to support these uses.
[Learn More]


* Please review the disclaimer below.